🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Purpose: Test whether intranasal administration of the neuropeptide, oxytoc...
Status
Completed
Location
University of North Carolina Hospitals
Start Date
2010-07
Trial ID
NCT01212185
Treatments Being Tested
Oxytocin (OT) is a neuropeptide that acts as a neurotransmitter and neuromo...
Status
Completed
Location
Biomedical Sciences
Start Date
2016-11-21
Trial ID
NCT03096249
This study will evaluate the effects on emotions and neural activity of a o...
Status
Completed
Location
Parkwood Hospital
Start Date
2013-09-12
Trial ID
NCT01937013
Treatments Being Tested
This study evaluates the effect of oxytocin nasal spray on alcohol withdraw...
Status
Completed
Location
Lade Addiction Treatment Center
Start Date
2016-10
Trial ID
NCT02903251
Treatments Being Tested
It has long been established that interpersonal relationships can have a pr...
Status
Completed
Location
UCLA Department of Psychology
Start Date
2015-01
Trial ID
NCT02393456
Treatments Being Tested
In this study, a randomized, placebo-controlled between-subject design is a...
Status
Completed
Location
KU Leuven
Start Date
2018-12-15
Trial ID
NCT04443647
The purpose of this study is to determine the effect of intranasal administ...
Status
Completed
Location
University Regional Hospital
Start Date
2014-04-29
Trial ID
NCT02301715
This study examines the effects of a single dose of intranasal oxytocin (vs...
Status
Completed
Location
Mount Sinai School of Medicine - Seaver Autism Center for Research and Treatment
Start Date
2010-06-18
Trial ID
NCT01183221
Treatments Being Tested
This study aims to investigate the potential beneficial effects of intranas...
Status
Recruiting
Location
University Hospital Basel
Start Date
2025-05-16
Trial ID
NCT06676774
Treatments Being Tested
This is a phase 2, double-blind, randomized, multicenter, placebo-controlle...
Status
Completed
Location
Preferred Research Partners, Inc.
Start Date
2022-12-06
Trial ID
NCT05679908
Treatments Being Tested